BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12167440)

  • 41. Racial disparities in incidence & survival of Kaposi's sarcoma in the United States.
    Kumar V; Soni P; Garg M; Hashmi AT; Chandra AB
    Indian J Med Res; 2019 Mar; 149(3):354-363. PubMed ID: 31249200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second cancer following cancers of the buccal cavity and pharynx in Connecticut, 1935-1982.
    Winn DM; Blot WJ
    Natl Cancer Inst Monogr; 1985 Dec; 68():25-48. PubMed ID: 4088301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues.
    Franceschi S; Bidoli E; Herrero R; Muñoz N
    Oral Oncol; 2000 Jan; 36(1):106-15. PubMed ID: 10889929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site.
    Jansen L; Buttmann-Schweiger N; Listl S; Ressing M; Holleczek B; Katalinic A; Luttmann S; Kraywinkel K; Brenner H;
    Oral Oncol; 2018 Jan; 76():8-15. PubMed ID: 29290288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
    Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
    J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stat bite: Incidence of and mortality from oral cavity and pharynx cancer, 1975-2002.
    J Natl Cancer Inst; 2006 Jan; 98(2):87. PubMed ID: 16418507
    [No Abstract]   [Full Text] [Related]  

  • 47. Stat bite: Incidence of and mortality from cancer of the oral cavity and pharynx.
    J Natl Cancer Inst; 2003 May; 95(9):639. PubMed ID: 12734308
    [No Abstract]   [Full Text] [Related]  

  • 48. Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010.
    Ligier K; Belot A; Launoy G; Velten M; Bossard N; Iwaz J; Righini CA; Delafosse P; Guizard AV;
    Oral Oncol; 2011 Apr; 47(4):302-7. PubMed ID: 21397551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
    Islami F; Fedewa SA; Jemal A
    Prev Med; 2019 Jun; 123():316-323. PubMed ID: 31002830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemiology of lip, oral cavity and pharyngeal cancers in Kuwait 1979-1988.
    Morris RE; Mahmeed BE; Gjorgov AN; Jazzaf HG; Rashid BA
    Br J Oral Maxillofac Surg; 2000 Aug; 38(4):316-9. PubMed ID: 10922158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States.
    Osazuwa-Peters N; Simpson MC; Massa ST; Adjei Boakye E; Antisdel JL; Varvares MA
    Oral Oncol; 2017 Nov; 74():90-97. PubMed ID: 29103758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals.
    Chidzonga MM
    Oral Oncol; 2006 Feb; 42(2):177-83. PubMed ID: 16256412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of Medicare Costs for Elderly Patients With Oral Cavity and Pharyngeal Cancers.
    Hollenbeak CS; Kulaylat AN; Mackley H; Koch W; Schaefer EW; Goldenberg D
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):628-35. PubMed ID: 26042925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Head and neck cancers: oral cavity, pharynx, and larynx.
    Tumino R; Vicario G
    Epidemiol Prev; 2004; 28(2 Suppl):28-33. PubMed ID: 15281603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of the epidemiology of oral and pharyngeal carcinoma: update.
    Saman DM
    Head Neck Oncol; 2012 Jan; 4():1. PubMed ID: 22244087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Racial disparity in stage at diagnosis and survival among adults with oral cancer in the US.
    Shiboski CH; Schmidt BL; Jordan RC
    Community Dent Oral Epidemiol; 2007 Jun; 35(3):233-40. PubMed ID: 17518970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral and pharyngeal cancer incidence and mortality among Hispanics, 1996-2002: the need for ethnoregional studies in cancer research.
    Cruz GD; Salazar CR; Morse DE
    Am J Public Health; 2006 Dec; 96(12):2194-200. PubMed ID: 17077408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence, mortality and survival rates of lip, oral cavity and salivary glands cancers in Singapore: A half-century time trend analysis (1968-2017).
    Peres MA; Li H; Nascimento GG; Leite FRM
    Community Dent Oral Epidemiol; 2024 Jun; 52(3):302-312. PubMed ID: 38462696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012.
    Shield KD; Ferlay J; Jemal A; Sankaranarayanan R; Chaturvedi AK; Bray F; Soerjomataram I
    CA Cancer J Clin; 2017 Jan; 67(1):51-64. PubMed ID: 28076666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends of head and neck cancers in urban and rural India.
    Elango JK; Gangadharan P; Sumithra S; Kuriakose MA
    Asian Pac J Cancer Prev; 2006; 7(1):108-12. PubMed ID: 16629526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.